Product Information
NORA-BE TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.0943 per EA under NDC 00480347516. Its NADAC has been published 122 times since Feb 28, 2024.
Strength
.35 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00480347516
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
NORETHINDRONEApproval Type
Authorized Generic (NDA)
FDA Application
NDA017060On Market Since
12/1/2023
Pharmacological Classes
Price Statistics
The NADAC for NORA-BE TABLET has been published 122 times since Feb 28, 2024, and over the history we have for it it has declined 14.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0943 per EA |
|---|---|
| All-time high | $0.1170 (Apr 10, 2024) |
| All-time low | $0.0691 (Nov 20, 2024) |
| 52-week high | $0.0945 |
| 52-week low | $0.0849 |
| Median price | $0.0902 |
| Average price | $0.0915 |
| Largest weekly change | +43.4% (Aug 21, 2024) |
| Weeks tracked | 122 |
| Tracking since | Feb 28, 2024 |
Generic Alternatives
The matcher finds 4 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 4 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of NORA-BE TABLET?
The current National Average Drug Acquisition Cost (NADAC) for NORA-BE TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $0.0943 per EA (NDC 00480347516), effective Jun 24, 2026.
How has the price of NORA-BE TABLET changed over time?
Over the history we have for it, the NADAC for NORA-BE TABLET has declined 14.7%. It has been tracked across 122 weekly CMS publications since Feb 28, 2024.
What are the highest and lowest recorded NADAC prices for NORA-BE TABLET?
Since Feb 28, 2024, the NADAC for NORA-BE TABLET has ranged from a low of $0.0691 (Nov 20, 2024) to a high of $0.1170 (Apr 10, 2024), with a median of $0.0902 per EA.
Are there cheaper alternatives to NORA-BE TABLET?
4 NADAC-published products share the same active ingredient, strength, and dosage form as NORA-BE TABLET, but none are currently priced below it.
Who manufactures NORA-BE TABLET?
NORA-BE TABLET (NDC 00480347516) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification